Evidence map›Paper›PMID 33998274›Full record

ArticlePharmacogenomics2021

Resolving discordant

Yaowaluck Hongkaew, Wendy Y Wang, Roger Gaedigk, Chonlaphat Sukasem, Andrea Gaedigk

Open access · greenAbstract read
In one paragraph

Article in Pharmacogenomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Characterization of NovelJournal of personalized medicine · 2022
    Article
  7. Pharmacogenomics · 2022
    Article
  8. Keeping pace withPharmacogenomics · 2022
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Yaowaluck HongkaewDepartment of Laboratory, Division of Advance Research & Development Laboratory, Bumrungrad International Hospital, Bangkok, Thailand.ORCID 0000-0002-4180-9696
Wendy Y WangDivision of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, MO 64108, USA.ORCID 0000-0002-0203-0196
Roger GaedigkDivision of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, MO 64108, USA.ORCID 0000-0001-5942-1609
Chonlaphat SukasemDepartment of Pathology, Division of Pharmacogenomics & Personalized Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand.ORCID 0000-0003-0033-5321
Andrea GaedigkDivision of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, MO 64108, USA.ORCID 0000-0001-6968-1893
Children's Mercy Hospital · USBumrungrad International Hospital · THMahidol University · TH

Funding

PHARMacogene VARiation ConsortiumR24GM123930 · NIGMS · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI GAEDIGK, ANDREA · 2017 to 2020
$1.9M
NIGMS NIH HHS R24 GM123930
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AllelesCytochrome P-450 CYP2D6DNA Copy Number VariationsGenotyping TechniquesHaplotypesHumansMultiplex Polymerase Chain ReactionPolymerase Chain ReactionThailandCytochrome P-450 CYP2D6CYP2D6genotypeLuminex xTAGrisperidoneThai

Identifiers

PMID33998274
PMCPMC8212855
OpenAlexW3161708153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.